Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts.
Zhang B, Liu M, Mai F, Li X, Wang W, Huang Q, Du X, Ding W, Li Y, Barwick B, Ni J, Osunkoya A, Chen Y, Zhou W, Xia S, Dong JT.
Zhang B, et al. Among authors: ni j.
J Clin Invest. 2024 May 23:e175949. doi: 10.1172/JCI175949. Online ahead of print.
J Clin Invest. 2024.
PMID: 38781024
Free article.